Let AI Prepare. Let People Decide.

Which pharmacovigilance (PV) decisions still need a qualified human behind them? 

AI can help reduce the reading, triage, and transcription surrounding safety decisions, but accountability still sits with people. 

As regulatory guidance increasingly emphasizes human oversight, transparency, and accountability, pharmaceutical organizations need to be ready to demonstrate exactly where automation ends, and human judgment begins.  

In our latest POV, Dr. Narayan Tripathi, Senior Director, Pharmacovigilance, examines five questions organizations should be prepared to answer about AI-assisted PV, and the governance needed to defend them with confidence. 

Read the POV to learn: 

  • Why preparation and decision-making require different approaches to AI 
  • What validation, monitoring, and auditability look like in an AI-assisted workflow 
  • Common mistakes that can introduce unnecessary inspection risk 
  • How human oversight can enable organizations to capture AI efficiencies without losing accountability 

Discover what an inspection-ready approach to AI can look like. 

Author
Narayan Tripathi
Senior Director, Pharmacovigilance

Dr. Narayan Tripathi is a seasoned and performance-driven healthcare professional with over 16 years of experience in Pharmacovigilance (PV). Currently serving as Senior Director of Pharmacovigilance at EVERSANA, he leads a team of over…